Table 1 Characteristics of patients with cirrhosis
Variable | Value |
|---|---|
Patients | 97 |
Sex (M/F) | 52/45 (53.6%/46.4%) |
Age (mean ± standard deviation, years) | 55.9 ± 12.32 |
 <60 yr | 55(56.7%) |
  ≥ 60 yr | 42(43.3%) |
Cause of liver cirrhosis | |
 Hepatitis B virus infection | 50(51.6%) |
 Hepatitis C virus infection | 1(1.0%) |
 Alcoholism | 10(10.3%) |
 Primary biliary cirrhosis | 12(12.4%) |
 Autoimmune hepatitis | 6(6.2%) |
 Wilson’s Disease | 1(1.0%) |
 Hepatolith | 1(1.0%) |
 Schistosomiasis Cirrhosis | 2(2.1%) |
 Cryptogenic Cirrhosis | 14(14.4%) |
Underling Conditions | |
 Hypertension | 18(18.6%) |
 Diabetes Mellitus | 18(18.6%) |
 Coronary Atherosclerotic Heart Disease | 3(3.1%) |
 Chronic Bronchitis and Emphysema Pulmonum | 2(2.1%) |
 Chronic kidney disease | 2(2.1%) |
Complications of liver cirrhosis | |
 Ascites | 66 (68.0%) |
 Hepatic encephalopathy | 21 (21.6%) |
 Hepatocellular carcinoma | 7 (7.2%) |
 Hepatorenal syndrome | 7 (7.2%) |
 Gastrointestinal bleeding | 8 (8.2%) |
 Bacterial infection | 30 (30.9%) |
 Pneumonia | 22 (22.7%) |
 SBP | 1 (1.0%) |
 Pneumonia and SBP | 2 (2.1%) |
 Urinary tract infection | 1 (1.0%) |
 Skin and soft tissue infection | 1 (1.0%) |
 Undetermined infection | 3 (3.1%) |
 ACLF | 13 (13.4%) |
  ACLF grade 1 | 3 (3.1%) |
  ACLF grade 2 | 9 (9.3%) |
  ACLF grade 3 | 1(1.0%) |
Transplant-free mortality | |
 28-days mortality | 20 (20.6%) |
 90-days mortality | 24 (24.7%) |
 180-days mortality | 29 (29.9%) |